First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release
NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.
In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.
As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.
Article
As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.
When the COVID-19 pandemic first hit, everyday staples like toilet paper and paper towels were suddenly seemingly nowhere to be found. Over-the-counter products, like fever reducers and cough medicine, were in high demand—along with hand sanitizer, disinfectant sprays and cleaning wipes.
Registration being accepted for `Demo Day’ next month to showcase the innovations
Press Release
OVERLAND PARK, Kan., September 22, 2020 /3BL Media/ – With the goal of delivering solutions to safeguard communities against COVID-19, Black & Veatch’s IgniteX COVID-19 Response Accelerator has launched five projects of new-to-market technologies at commercial sites in the United States. Based on these early successes, Black & Veatch has announced it is doubling its funding goal for the program to $500,000.
Breathing. Nothing comes more naturally to us. Here in 2020, there may be nothing more imperative to protecting both personal and global health than breathing through the new daily staple: a mask on every face.
Together with the support of VF’s product design and development teams, our JanSport® and Eagle Creek® brands have developed a range of new consumer mask choices that are not only fashionable, functional and compliant, but produced in an environmentally responsible manner.
What’s the news: T-Mobile and students at the University of Kansas are teaming up this fall to research and develop 5G solutions that can revolutionize the future of nursing.
Why it matters: With the move to virtual education, creative new approaches using advanced technology to train healthcare workers and nursing students is needed now more than ever.
Who it’s for: Anyone that relies on nurses for their health and well-being – so basically everyone.
Press Release
What’s the news: T-Mobile and students at the University of Kansas are teaming up this fall to research and develop 5G solutions that can revolutionize the future of nursing.
Why it matters: With the move to virtual education, creative new approaches using advanced technology to train healthcare workers and nursing students is needed now more than ever.
Who it’s for: Anyone that relies on nurses for their health and well-being – so basically everyone.
In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
As we head into fall, how is COVID-19 testing going? Lisa Ling speaks to experts, including Ann Lee, co-founder, with actor Sean Penn, of the nonprofit CORE, to get the latest updates on testing efforts and contact tracing across America.
With a global pandemic still raging in parts of the world, Medtronic is helping stretched-thin clinicians work quickly, safely, and efficiently with the help of remote technology.
Article
When the COVID-19 crisis was hitting its apex in New York earlier this year, doctors needed a way to remotely monitor the vital signs of patients admitted to a large convention center that had been converted into a field hospital.
So, a team from Medtronic quickly installed several of the company’s technologies to create a system that allowed about 10 clinicians to remotely monitor about 400 patients at the Jacob K. Javits Convention Center.
Getting such an operation up and running normally takes weeks or months … Medtronic did it over a weekend.
